MARC record from Internet Archive

LEADER: 03415cam 2200757 a 4500
001 ocm28749338
003 OCoLC
005 20221024111546.0
008 930826s1992 txua b 001 0 eng
040 $aNLM$beng$cNLM$dEET$dAGX$dTMV$dBAKER$dCGC$dYDXCP$dDEBBG$dVAM$dBDX$dGBVCP$dOCLCF$dOCLCQ$dOCLCO$dOCLCQ$dUKMGB$dOCLCO$dOCL
016 7 $a9314425$2DNLM
016 7 $a011055853$2Uk
019 $a27247573
020 $a9781879702042
020 $a1879702045
035 $a(OCoLC)28749338$z(OCoLC)27247573
050 14 $aRC116.G677 B87 1992
060 00 $aWC 200$bB949i 1992
072 0 $aX380
084 $aYD 3015$2rvk
100 1 $aBurd, Randall S.
245 10 $aImmunotherapy of gram-negative bacterial sepsis /$cRandall S. Burd, Carolyn S. Cody, David L. Dunn.
260 $aAustin :$bR.G. Landes,$c1992.
300 $av, 125 pages :$billustrations.
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
490 1 $aMedical intelligence unit
504 $aIncludes bibliographical references (pages 95-117) and indexes.
505 0 $aClinical problem -- Historical perspective -- Current epidemiology -- Clinical presentation and manifestations -- Definition and classification schemes -- Standard therapy of gram-negative bacterial infections -- Endotoxemia -- Structure of endotoxin -- Overview -- O-antigen polysaccharide -- Core polysaccharide -- Lipid A -- Host responses to endotoxin -- Pathophysiology of gram-negative bacterial infection -- Immune responses to endotoxin -- New treatment modalities -- Historical perspective -- Therapeutic endotoxin clearance -- Lipid A analogs -- Bactericidal/permeability-increasing protein -- Therapeutic blockade of cytokine responses -- Antibody immunotherapy of gram-negative bacterial sepsis -- New directions.
540 $aCurrent Copyright Fee: GBP22.12$c0.$5Uk
650 0 $aGram-negative bacterial infections.
650 0 $aBacterial diseases.
650 0 $aSepticemia.
650 0 $aImmunotherapy.
650 2 $aEndotoxins$ximmunology
650 2 $aGram-Negative Bacterial Infections$xdrug therapy
650 2 $aGram-Negative Bacterial Infections$ximmunology
650 2 $aImmunotherapy
650 2 $aSepsis
650 6 $aInfections à bactéries Gram négatives.
650 6 $aMaladies bactériennes.
650 6 $aSepticémie.
650 6 $aImmunothérapie.
650 7 $aImmunotherapy.$2fast$0(OCoLC)fst00968044
650 7 $aBacterial diseases.$2fast$0(OCoLC)fst00825196
650 7 $aGram-negative bacterial infections.$2fast$0(OCoLC)fst00946121
650 7 $aSepticemia.$2fast$0(OCoLC)fst01112835
650 7 $aGram-negative Bakterien$2gnd
650 7 $aImmuntherapie$2gnd
650 7 $aSepsis$2gnd
700 1 $aCody, Carolyn S.
700 1 $aDunn, David L.
830 0 $aMedical intelligence unit.
856 41 $3Table of contents$uhttp://www.gbv.de/dms/bowker/toc/9781879702042.pdf
938 $aBaker & Taylor$bBKTY$c89.95$d94.90$i1879702045$n0002267052$sactive
938 $aBrodart$bBROD$n47569379$c$89.95
938 $aYBP Library Services$bYANK$n1233227
029 0 $aNLM$b9314425
029 1 $aAU@$b000009453697
029 1 $aDEBBG$bBV008245860
029 1 $aGBVCP$b137439105
029 1 $aNLGGC$b20005189X
029 1 $aUKMGB$b011055853
994 $aZ0$bGTX
948 $hNO HOLDINGS IN GTX - 73 OTHER HOLDINGS